With so many recent stories of pharma layoffs, at least the latest story in that realm is only indirectly related to pharma, as Procter & Gamble Co.—which announced it would slash 5,700 this year and cut $10 billion over the next few years—is a large consumer products company and not a Big Pharma player.
Procter & Gamble to cut 5,700 jobs and $10 billion
Procter & Gamble Co plans to cut a total of 5,700 non-manufacturing jobs as part of a new plan to reduce costs by $10 billion by the end of fiscal 2016
To continue reading this article, subscribe for FREE to
Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.
About the Author
- This person does not yet have a bio.







